Healthcare · Biotechnology
Price
$37.93
Market Cap
$715.7M
Employees
51
Beta
0.14
Avg Volume
194,901
CEO
Alise S. Reicin
Business Description
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Business History
Price Overview
Price at report time · Jul 3, 6:46am (0m ago)
$37.93
Change · Jul 3
+5.19 (+15.85%)
Day Range
$32.13 – $38.12
52-Week Range
$14.39 – $38.12
50-Day MA
$29.49
200-Day MA
$23.76
Volume
478,429.00
Right now · live
loading…
Real-time — the change above is the move since the report (over 0m).
Analyst Price Targets
Low
$60.00
Consensus
$72.00
High
$81.00
(3 analysts)
Share Structure
Outstanding
18,869,186.00
Float
11,233,581.00
Free Float
59.5%
Normal free float
— 59.5% of shares trade freely, ~40.5% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-9.37
Stock Price: $37.93
EPS (Diluted): -4.05
EPS (Diluted): -4.05
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
1.52
Stock Price: $37.93
Total Equity: $251.33M
Shares: 18,322,533
Total Equity: $251.33M
Shares: 18,322,533
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-6.00
Market Cap: $715.71M
Total Debt: $43,000
Cash: $253.80M
EBITDA: -$71.48M
Total Debt: $43,000
Cash: $253.80M
EBITDA: -$71.48M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$129.7M
Market Cap: $715.71M
Total Debt: $43,000
Cash: $253.80M
Total Debt: $43,000
Cash: $253.80M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $37.93
Revenue: $0.00
Shares: 18,322,533
Revenue: $0.00
Shares: 18,322,533
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$84.04M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$74.15M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-32.3%
Net Income: -$74.15M
Total Equity: $251.33M
Total Equity: $251.33M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-39.6%
Operating Income: -$84.04M
Tax Rate: -1.7%
Equity: $251.33M
Total Debt: $43,000
Cash: $253.80M
Tax Rate: -1.7%
Equity: $251.33M
Total Debt: $43,000
Cash: $253.80M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
26.63
Current Assets: $257.36M
Current Liabilities: $9.67M
Current Liabilities: $9.67M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $43,000
Total Debt: $43,000
Total Equity: $251.33M
Long-Term Debt: $43,000
Total Debt: $43,000
Total Equity: $251.33M
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 18,322,533
Shares: 18,322,533
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$13.72
Total Equity: $251.33M
Shares: 18,322,533
Shares: 18,322,533
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-3.29
Operating CF: -$60.08M
CapEx: -$208,000
Shares: 18,322,533
CapEx: -$208,000
Shares: 18,322,533
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $37.93
Stock Price: $37.93
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$74.15M
Net Income: -$74.15M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares TECX against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 3, 2026 6:46am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Operating Expenses | $15.6M | $32.8M | $44.6M | $58.0M | $84.0M |
| Operating Income | -$15.6M | -$32.8M | -$44.6M | -$58.0M | -$84.0M |
| Net Income | -$8.9M | -$32.2M | -$42.8M | -$58.0M | -$74.2M |
| EBITDA | -$8.1M | -$31.0M | -$41.2M | -$56.2M | -$71.5M |
| EPS | $-33.36 | $-29.05 | $-11.59 | $-3.93 | $-4.05 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jul 3, 2026 6:46am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $28.1M | $36.0M | $28.8M | $141.2M | $253.8M |
| Total Current Assets | $28.6M | $37.0M | $30.9M | $146.9M | $257.4M |
| Total Assets | $32.9M | $47.2M | $39.4M | $152.9M | $261.0M |
| Current Liabilities | $4.1M | $7.8M | $40.9M | $11.6M | $9.7M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $43,000 |
| Total Liabilities | $47.8M | $92.9M | $124.0M | $12.1M | $9.7M |
| Total Equity | -$15.0M | -$45.7M | -$84.6M | $140.8M | $251.3M |
| Retained Earnings | -$15.6M | -$47.8M | -$90.6M | -$148.6M | -$222.7M |
Cash Flow (Annual)
Last updated: Jul 3, 2026 6:46am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$12.5M | -$97.2M | -$40.7M | -$59.1M | -$60.1M |
| Capital Expenditure | -$2.1M | $-267,000 | $-279,000 | $-156,000 | $-208,000 |
| Free Cash Flow | -$14.6M | -$97.5M | -$41.0M | -$59.2M | -$60.3M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $70,000 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $26.8M | -$96.7M | -$7.2M | $112.5M | $113.0M |
Analyst Estimates (Annual)
Last updated: Jul 3, 2026 6:46am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue | $0 | $0 |
$41.7M $41.7M – $41.7M
|
$147.4M $147.4M – $147.4M
|
| EBITDA | $0 | $0 | $0 | $0 |
| Net Income |
-$101.7M -$110.7M – -$92.8M
|
-$104.3M -$164.7M – -$43.8M
|
-$132.0M -$132.0M – -$132.0M
|
-$94.4M -$94.4M – -$94.4M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jul 3, 2026 6:46am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | -110.3% | -36.0% | -29.9% | -44.9% |
| Net Income Growth | -260.5% | -33.1% | -35.4% | -27.9% |
| EBITDA Growth | -282.2% | -32.8% | -36.5% | -27.1% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-30 | McNamara Peter | M-Exempt | 172.00 | $14.71 | $2,530 |
| 2026-06-30 | McNamara Peter | S-Sale | 172.00 | $35.00 | $6,020 |
| 2026-06-30 | McNamara Peter | M-Exempt | 172.00 | $14.71 | $2,530 |
| 2026-06-20 | REICIN ALISE | F-InKind | 924.00 | $30.34 | $28,034 |
| 2026-06-11 | Lochner Daniel | A-Award | 7,500.00 | $16.80 | $126,000 |
| 2026-06-09 | SPRINGER TIMOTHY A | A-Award | 10,200.00 | $28.56 | $291,312 |
| 2026-06-09 | Tipirneni Praveen P. | A-Award | 10,200.00 | $28.56 | $291,312 |
| 2026-06-09 | Donenberg Phillip B. | A-Award | 10,200.00 | $28.56 | $291,312 |
| 2026-06-09 | Vitorovic Stefan | A-Award | 10,200.00 | $28.56 | $291,312 |
| 2026-06-08 | Chutter Jessica Caroline | A-Award | 20,400.00 | $29.10 | $593,640 |
| 2026-06-08 | Chutter Jessica Caroline | 0.00 | $0.00 | $0 | |
| 2026-05-04 | Ruddy Marcella K. | S-Sale | 1,065.00 | $30.00 | $31,950 |
| 2026-04-01 | Ruddy Marcella K. | S-Sale | 1,000.00 | $31.05 | $31,050 |
| 2026-04-01 | Nader Francois | A-Award | 20,400.00 | $30.78 | $627,912 |
| 2026-04-01 | Nader Francois | 0.00 | $0.00 | $0 | |
| 2026-03-06 | Ruddy Marcella K. | S-Sale | 10,000.00 | $30.00 | $300,000 |
| 2026-03-06 | McNamara Peter | M-Exempt | 215.00 | $14.71 | $3,163 |
| 2026-03-06 | McNamara Peter | M-Exempt | 2,500.00 | $2.38 | $5,950 |
| 2026-03-06 | McNamara Peter | S-Sale | 6,047.00 | $30.00 | $181,410 |
| 2026-03-06 | McNamara Peter | S-Sale | 215.00 | $35.00 | $7,525 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for TECX — it's generated by the pipeline (
market-narrative step).
No community reviews yet for TECX.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.373 · 697c9e64 · 2026-07-02 20:17:59